Epalrica-M Tablet SR
Marketer
Ordain Health Care Global Pvt Ltd
Salt Composition
Epalrestat (150mg) + Methylcobalamin (1500mcg)
Overview Epalrica-M Tablet SR
Diabetic neuropathy is treated with the extended-release Epalrica-M Tablet SR, which safeguards nerve fibers and encourages nerve cell repair. To prevent further nerve damage, it's used alongside other blood glucose-reducing drugs. Epalrica-M Tablet SR can be taken with or without food, but consistent daily timing is recommended. Dosage is determined by your physician; discontinuation requires medical consultation, as cessation may elevate blood sugar, potentially leading to severe complications such as renal impairment or vision loss. This medication is part of a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Common, typically transient side effects include nausea, vomiting, and elevated liver enzymes. Persistent or worsening symptoms necessitate medical attention. Prior to commencing treatment, disclose any kidney or liver conditions, urinary tract infections, diuretic use, or pregnancy/breastfeeding to your doctor. Limit alcohol consumption during treatment to minimize potential side effects. Regular blood glucose monitoring is essential while using this medication.
Primary Ingredients of Epalrica-M Tablet SR
No text provided. Please provide the text you want me to rephrase.
Uses of Epalrica-M Tablet SR
Peripheral neuropathy in diabetes
Major Benefits of Epalrica-M Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Epalrica-M SR Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistent timing is recommended.
Common Side effects of Epalrica-M Tablet SR:
- Nausea
- Vomiting
- Increased liver enzymes
How to use Epalrica-M Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Epalrica-M Extended-Release Tablets may be consumed with or without food, although consistent timing is recommended.
How Epalrica-M Tablet SR works:
Epalrica-M sustained-release tablets contain a dual medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Epalrica-M SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Epalrica-M Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on Epalrica-M Tablet SR use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Epalrica-M Tablet SR on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Epalrica-M Tablet SR's efficacy and safety in individuals with renal impairment. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Epalrica-M Tablet SR use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Epalrica-M Tablet SR :
NA
Facts to Know About Epalrica-M Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently